|
PSMB5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.447400E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.245500E-04 |
| Normal-vs-Stage2 |
1.372020E-02 |
| Normal-vs-Stage3 |
9.149400E-01 |
| Normal-vs-Stage4 |
8.932200E-01 |
| Stage1-vs-Stage2 |
6.471600E-01 |
| Stage1-vs-Stage3 |
3.047600E-02 |
| Stage1-vs-Stage4 |
4.142500E-02 |
| Stage2-vs-Stage3 |
5.416500E-02 |
| Stage2-vs-Stage4 |
9.667800E-02 |
| Stage3-vs-Stage4 |
9.561000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.74929999999485E-05 |
| Normal-vs-AfricanAmerican |
9.265600E-02 |
| Normal-vs-Asian |
8.971000E-01 |
| Caucasian-vs-AfricanAmerican |
5.988400E-02 |
| Caucasian-vs-Asian |
4.086000E-01 |
| AfricanAmerican-vs-Asian |
6.192600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.75000000000636E-05 |
| Normal-vs-Female |
1.409830E-01 |
| Male-vs-Female |
2.016100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.217700E-02 |
| Normal-vs-Extreme_Weight |
1.437390E-03 |
| Normal-vs-Obese |
3.832200E-02 |
| Normal-vs-Extreme_Obese |
1.341800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.996800E-01 |
| Normal_Weight-vs-Obese |
8.446400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.114200E-01 |
| Extreme_Weight-vs-Obese |
3.051400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.689400E-01 |
| Obese-vs-Extreme_Obese |
6.173800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.321200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.019400E-03 |
| Normal-vs-Age(61-80Yrs) |
7.77480000000441E-05 |
| Normal-vs-Age(81-100Yrs) |
3.550300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.682000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.979100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.338080E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.841400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.966100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.242000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.794120E-04 |
| Normal-VS-Type2 PRCC |
1.913630E-02 |
| Normal-VS-KIRP CIMP |
4.238600E-01 |
| Normal-VS-Unclassified PRCC |
1.478430E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.897200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.778700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.468600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.109600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.940000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.499500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.655600E-02 |
| Normal-vs-N1 |
6.936400E-01 |
| Normal-vs-N2 |
4.482700E-03 |
| N0-vs-N1 |
7.958300E-02 |
| N0-vs-N2 |
3.471600E-01 |
| N1-vs-N2 |
1.103610E-01 |
|
|
